Contraception News and Research

Latest Contraception News and Research

Does fetal fibronectin testing change patient management in women at risk of preterm labour?

Hologic, Inc. has announced the publication of the first of its kind study evaluating the impact of fetal fibronectin (fFN) testing among both symptomatic and asymptomatic pregnant women at risk for preterm birth. The study, "Does fetal fibronectin testing change patient management in women at risk of preterm labour?" by researchers at King's College, London, England appears in the on-line version of the European Journal of Obstetrics & Gynecology and Reproductive Biology.

20 Aug 2009

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.

20 Aug 2009

Appeals court affirms invalidation of Yasmin patent

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No. 6,787,531 invalid. The patent is listed in the Orange Book for Bayer's oral contraception Yasmin®.

5 Aug 2009

Researchers identify women at risk of gaining excessive weight with Depo-Provera

Researchers at the University of Texas Medical Branch at Galveston have identified women who are likely to gain weight while using depot medroxyprogesterone acetate, more commonly known as Depo-Provera or the birth control shot. These findings dispel the myth that all women who use DMPA will gain weight and will help physicians to counsel patients appropriately.

24 Jul 2009

Abortion issue could derail health reform

Nineteen Democrats have written House Speaker Nancy Pelosi promising not to vote for a health bill that includes funding for abortion, igniting a debate that has the potential to derail a health care overhaul, NPR reports.

15 Jul 2009

Why oral contraceptives fail for obese women

Researchers have identified a potential biological mechanism that could explain why oral contraceptives may be less effective at preventing pregnancy in obese women, as some epidemiological studies have indicated.

14 Jul 2009

IRIN examines 'dramatic plunge' in family planning international donor dunding

IRIN examines how a "dramatic plunge" in international donor funding for family planning could undermine other health- and humanitarian-related goals, including fighting poverty and hunger. About 200 million women do not have access to contraception, which could cause a surge in the world's population leading to a reversal of humanitarian gains, according to some experts.

13 Jul 2009

Two reproductive factors are important predictors of death from ovarian cancer

Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.

9 Jul 2009

FDA approves Hologic's permanent contraception system

Hologic, Inc.today announced the U.S. Food and Drug Administration (FDA) has approved the Company's premarket approval (PMA) application for the Adiana permanent contraception system.

From Hologic, Inc. 7 Jul 2009

PATRICIA trial shows HPV vaccine effective in prevention of cervical lesions

The final analysis of the PATRICIA study shows that the HPV-16/18 AS04-adjuvanted vaccine (GlaxoSmithKline) has high efficacy against the precancerous cervical lesions that can eventually lead to cervical cancer.

6 Jul 2009

FDA approves generic emergency contraceptive Plan B (levonorgestrel) tablets

The U.S. Food and Drug Administration today approved the first generic version of the emergency contraceptive Plan B (levonorgestrel) tablets, 0.75 mg. The generic product will be available by prescription only for women ages 17 and under.

24 Jun 2009

Women warned not to wait too long to have a baby

Women are being warned that they should consider starting a family before the age of 35 or they will risk missing out on motherhood.

21 Jun 2009

Easier access to media by children increases risk for influence on numerous health issues

With children having easier access to media and a wider variety of content, the possible negative influence on health issues such as sex, drugs, obesity and eating disorders is increased, and warrants monitoring usage and limiting access if necessary, according to a commentary in the June 3 issue of JAMA, the Journal of the American Medical Association, a theme issue on child and adolescent health.

2 Jun 2009

Sex education in Singapore's schools should provide teens with objective, reliable information, Education Ministry says

The number of teenagers contracting HIV and other sexually transmitted infections has increased over the past several years, Singapore's Education Minister Ng Eng Hen said on Thursday, the Straits Times reports.

26 May 2009

Doctors explore myths, half-truths, and outright lies about health

Fact or fiction? Chewing gum stays in your stomach for seven years. Cold weather makes you sick. You should never wake a sleepwalker. A dog's mouth is cleaner than a human's.

26 May 2009

Couples to rely on new male contraceptive for new trial

Couples are being asked to replace their usual form of birth control with a new male contraceptive in a study to test its effectiveness.

From The University of Manchester 20 May 2009

Sex ‘too early’ a cause of regret and disappointment for many young girls

A study carried out by researchers from the University of Western Australia (UWA) has found that teenage girls who lose their virginity when they are not ready, often at an earlier age, are more likely to feel disappointment and regret the experience.

19 May 2009

New vaginal ring designed to prevent sexual transmission of HIV

Researchers from Weill Cornell Medical College have published results showing that a new contraceptive device may also effectively block the transmission of the HIV virus. Findings show that the device prevents infection by the HIV virus in laboratory testing. The promising results are published in the most recent issue of the journal AIDS.

19 May 2009

Discovery of two proteins essential for ovulation

Researchers from the National Institutes of Health and other institutions have identified in mice two proteins essential for ovulation to take place.

14 May 2009

Injectable androgen preparation may provide effective male contraception

Researchers in China may have found a method for male contraception that is effective, reversible and without serious short-term adverse effects according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

4 May 2009